Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis - PubMed (original) (raw)

Review

. 2016 Aug 15:785:165-173.

doi: 10.1016/j.ejphar.2015.05.072. Epub 2015 Jul 9.

Affiliations

PMID: 26165764
DOI: 10.1016/j.ejphar.2015.05.072

Review

Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis

Patricia R Souza et al. Eur J Pharmacol. 2016.

Abstract

Omega-3 polyunsaturated fatty acids are essential for health and are known to possess anti-inflammatory properties, improving cardiovascular health as well as benefiting inflammatory diseases. Indeed, dietary supplementation with omega-3 polyunsaturated fatty acids has proved efficacious in reducing joint pain, morning stiffness and nonsteroidal anti-inflammatory drugs usage in rheumatoid arthritis patients. However, the mechanisms by which omega-3 polyunsaturated fatty acids exert their beneficial effects have not been fully explored. Seminal discoveries by Serhan and colleagues have unveiled a novel class of bioactive lipid mediators that are enzymatically biosynthesized in vivo from omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), termed resolvins, protectins and maresins. These bioactive pro-resolving lipid mediators provide further rationale for the beneficial effects of fish-oil enriched diets. These endogenous lipid mediators are spatiotemporally biosynthesized to actively regulate resolution by acting on specific G protein-coupled receptors (GPCRs) to initiate anti-inflammatory and pro-resolving signals that terminate inflammation. In this review, we will discuss the mechanism of actions of these molecules, including their analgesic and bone-sparing properties making them ideal therapeutic agonists for the treatment of inflammatory diseases such as rheumatoid arthritis.

Keywords: Arthritis; Inflammation; Omega-3; Resolution; Resolvins.

PubMed Disclaimer

Cited by

Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis.
Günay S, Taşova F, Yılmaz HE, Paköz ZB, Çekiç C. Günay S, et al. Gastroenterol Res Pract. 2019 Feb 14;2019:6258327. doi: 10.1155/2019/6258327. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 30906319 Free PMC article.
Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis.
Tomic-Smiljanic M, Vasiljevic D, Lucic-Tomic A, Andjelkovic N, Jakovljevic V, Bolovich S, Veselinovic M. Tomic-Smiljanic M, et al. Clin Rheumatol. 2019 Sep;38(9):2443-2450. doi: 10.1007/s10067-019-04569-3. Epub 2019 May 10. Clin Rheumatol. 2019. PMID: 31076942 Clinical Trial.
Stretching Impacts Inflammation Resolution in Connective Tissue.
Berrueta L, Muskaj I, Olenich S, Butler T, Badger GJ, Colas RA, Spite M, Serhan CN, Langevin HM. Berrueta L, et al. J Cell Physiol. 2016 Jul;231(7):1621-7. doi: 10.1002/jcp.25263. Epub 2015 Dec 10. J Cell Physiol. 2016. PMID: 26588184 Free PMC article.
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis-a Complex Field with Significant Potential for Future Treatments.
Mustonen AM, Nieminen P. Mustonen AM, et al. Curr Rheumatol Rep. 2021 Apr 28;23(6):41. doi: 10.1007/s11926-021-01007-9. Curr Rheumatol Rep. 2021. PMID: 33913032 Free PMC article. Review.
Oil Pulling and Polyphenols: Treatment of Gingivitis Patients with 'Itri Extra-Virgin Olive Oil'.
Zumbo G, Corridore D, Sciscione S, Stamegna C, Guerra F, Polimeni A, Vozza I. Zumbo G, et al. J Clin Med. 2023 Aug 12;12(16):5256. doi: 10.3390/jcm12165256. J Clin Med. 2023. PMID: 37629298 Free PMC article.

Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis - PubMed (original) (raw)

Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials